Taiwan FDA registration 4d51f83aca559a1d04b2f0bb3c8d91d3
Shiji 5801 electrophoresis test kit
TW: 世基5801電泳檢測套組
Taiwan·Risk Class 2·Shiji Biomedical Co., Ltd. Taipei Plant·Registered Sep 18, 2012 – Sep 18, 2022CancelledRegistration details
- Analysis ID
- 4d51f83aca559a1d04b2f0bb3c8d91d3
Company information
- Manufacturer
- Shiji Biomedical Co., Ltd. Taipei Plant
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- PHARMIGENE, INC.
Product details
- Intended Use
- The Shiji 5801 electrophoresis test set was used to qualitatively detect HLA-B*5801 gene by polymerase chain reaction technology.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3360 Genotype testing system for drug metabolic enzymes
- Import Information
- Domestic
Dates and status
- Registration Date
- Sep 18, 2012
- Expiry Date
- Sep 18, 2022
- Cancellation Date
- Apr 12, 2024
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Shiji 5801 electrophoresis test kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4d51f83aca559a1d04b2f0bb3c8d91d3 and manufactured by Shiji Biomedical Co., Ltd. Taipei Plant. The authorized representative in Taiwan is PHARMIGENE, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices